This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Should You Invest in the Invesco S&P SmallCap Health Care ETF (PSCH)?
by Zacks Equity Research
Sector ETF report for PSCH
4 Sector ETFs in Focus as US Economy Appears in Late Cycle
by Sanghamitra Saha
The U.S. economy appears in late business cycle and these sector ETFs should thus be in focus.
Don't Fear Yield Curve Inversion, Play These Top ETFs Instead
by Sanghamitra Saha
Inverted yield curve is not as scary as it seems to be. Wall Street staged a rally on many such occasions. So, investors can easily bet on these top-ranked ETFs.
Should You Invest in the Invesco S&P SmallCap Health Care ETF (PSCH)?
by Sweta Killa
Sector ETF report for PSCH
ETF Assets Swell in July: What's Hot, What's Not
by Sanghamitra Saha
There was a solid asset flow into the S&P 500 and corporate bond ETFs in July.
ETF Predictions for a Historically Low August
by Sanghamitra Saha
August saw an awful start with global markets in the red mainly due to renewed trade tensions. Such market and ETF activities could rule the market in August.
Q2 Earnings Surprise in the Cards, Healthcare ETFs to Buy
by Sweta Killa
With earnings surprise in cards, the healthcare sector is expected to witness earnings growth of 1.7% in the second quarter, suggesting continued outperformance for healthcare ETFs.
Healthcare ETFs in Focus on UnitedHealth's Q2 Earnings
by Sweta Killa
ETFs having the largest allocation to this health insurance giant are in focus post Q2 earnings.
Healthcare ETFs in Focus on JNJ's Q2 Earnings Beat
by Sweta Killa
Johnson & Johnson beat the second-quarter earnings and revenue estimates but warned on competition from generics and biosimilars that could impact its third-quarter results.
Should You Invest in the Invesco S&P SmallCap Health Care ETF (PSCH)?
by Zacks Equity Research
Sector ETF report for PSCH
4 Winning Sector ETFs & Stocks Post June Jobs Data
by Sanghamitra Saha
U.S. jobs data for the month of June beat estimates and is likely to benefit these sector ETFs and stocks.
4 ETFs to Bet on Global Aging Population
by Sanghamitra Saha
The average life expectancy will rise to 73 in 2025 from 65 years in 1995, per Global X report. Investors can cash in on the trend with these ETFs.
ETFs & Stocks From Top-Ranked Sector to Buy
by Sweta Killa
Investors could be well served by ETFs and stocks from sectors that house top-ranked industries.
Best ETF Ideas for the Second Half of 2019
by Neena Mishra
We discuss how investors should position their portfolios for the second half of 2019.
Should You Invest in the Invesco S&P SmallCap Health Care ETF (PSCH)?
by Sweta Killa
Sector ETF report for PSCH
Should You Invest in the Invesco S&P SmallCap Health Care ETF (PSCH)?
by Sweta Killa
Sector ETF report for PSCH
Play Strong Earnings Beat With These Top-Ranked Sector ETFs
by Sanghamitra Saha
S&P 500 earnings reported so far have come with an earnings beat that is second highest in five years. These sector ETFs should benefit from this trend.
April ETF Asset Report: U.S. Equities & Treasuries Win
by Sanghamitra Saha
U.S. equities and treasuries raked in a solid asset base in April.
Can Q1 Earnings Lift Healthcare ETFs Higher?
by Sweta Killa
With negative earnings revisions, the healthcare sector is expected to witness earnings growth of 1.8% in the first quarter, suggesting smooth trading for healthcare ETFs.
UnitedHealth Falls Despite Q1 Beat, Healthcare ETFs in Focus
by Sweta Killa
UnitedHealth Group reported robust first-quarter 2019 results. The company breezed past the Zacks Consensus Estimate on both earnings and revenues and raised its full-year forecast.
JNJ Beats, Ups Sales Growth View: Healthcare ETFs in Focus
by Sweta Killa
Johnson & Johnson continued its long streak of earnings beat and also outpaced revenue estimates. Though it raised the guidance for full-year sales growth, it tightened the earnings per share forecast.
Healthcare's Near-Term Prospects Bright: 3 ETFs in Focus
by Sweta Jaiswal, FRM
The healthcare space might have seen a sluggish year so far. But its valuation and near-term prospects make it a good space for investments right now.
Beat Q1 Earnings Woes With These Sector ETFs & Stocks
by Sweta Killa
The Q1 earnings picture looks bleak with projected growth turning negative for the first time since the second quarter of 2016.
Health Day Checkup of Medical ETFs: 5 Top Picks
by Sanghamitra Saha
M&A activity, approval of novel drugs and earnings growth in Q1 put healthcare ETFs in a decent spot.
Should You Invest in the Invesco DWA Healthcare Momentum ETF (PTH)?
by Zacks Equity Research
Sector ETF report for PTH